rhodioloside has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Huang, L; Huang, Z; Lin, W; Lv, C; Wang, L; Yang, S; Zhu, X | 1 |
1 other study(ies) available for rhodioloside and Osteogenic Sarcoma
Article | Year |
---|---|
Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Osteosarcoma; Phenols; Signal Transduction; STAT3 Transcription Factor | 2019 |